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Aim: Exertional angina in patients with no coronary ﬂow limiting lesions remains a clinical puzzle. We aimed to
assess the extent of coronary artery calciﬁcation (CAC) and its relationship to ventricular wall motion function
using stress echocardiography in a group of patients limited by exertional angina, but no obstructive lesions.
Methods: We compared CT coronary calcium score (CACS) and dobutamine stress echocardiography in 55
patients (age 64.7 ± 7.7 years), divided into Group 1 (CACS ≤ 100) and Group 2 (CACS N 100). No patient had
LV ejection fraction-EF b 55%, pulmonary hypertension, arrhythmia, renal failure or parathyroid disease. Multiple
linear regression analysis was used to test the association between gender-standardized continuous echocardio-
graphic parameters and patient groups adjusted for age, body surface area, osteoporosis and CV risk factors and
CACS.
Results: At rest, LV long axis ‘subendocardial’ function was reduced (amplitude: β−1.11 SD, p b 0.05, R2 0.6 and
systolic velocity:β−1.08 SD, p b 0.05, R2 0.44), left atrial (LA) indexed volumewas raised (β 1.06 SD, p b 0.05, R2
0.37) and its systolic velocity decreased (β−1.05 SD, p b 0.05, R2 0.35) inGroup 2.With stress,wallmotion score
index increased (p b 0.05) and long axis disturbances worsened only in the same group. Multivariate analysis
demonstrated clear relationship between ischaemic LV disturbances, reduced long axis amplitude, global longi-
tudinal systolic strain and early diastolic strain rate. Resting and stress RV lengthening velocity also correlated
with CAC score.
Conclusion: In symptomatic patientswith no obstructive coronary lesions andwithmore thanmild CAC, long axis
disturbances and wall motion score index rise occur with stress, at the time of symptom development and cor-
relate with severity of arterial calciﬁcation. These ﬁndings suggest CAC as a potential mechanism for coronary
wall stiffness and consequently exertional ischaemic changes as a result of limited ﬂow reserve.© 2014 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Atherosclerosis is a systemic disease with direct implications on car-
diovascular (CV) function. Approximately 50% of acute coronary syn-
dromes (ACS) are not preceded by symptoms and almost 30% have no
ﬂow limiting lesions (b50% stenosis) thus negating luminal stenosis as
the only cause for symptoms, [1] hence the need for stringent non-
invasive investigations to assess in detail arterial wall structure andPalmerini).
en access article under the CC BY-NCfunction as a potential cause for compromised coronary ﬂow reserve.
Computed Tomography (CT) scanning for coronary artery calciﬁcation
score (CACS) has emerged as an ideal tool for such objective, providing
accurate localization and quantiﬁcation of the extent of coronary
calciﬁcation. Patients limited by angina but with no signiﬁcant (b50%)
stenosis ‘Syndrome X’ represent another clinical dilemma, as for the
exact mechanism behind their symptoms [2]. We hypothesize that a
subset of those patients have severe CAC which could compromise
coronary ﬂow reserve at the time of symptoms. To test this hypothesis
we designed the current study to assess a group of such symptomatic
patients using CACS and compare it with cardiac function using stress-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ing coronary artery disease [3].
2. Methods
2.1. Study design and population
We prospectively recruited a consecutive group of patients who
presented to Umeå Heart Centre, between 2009 and 2011, with exer-
tional angina but not evidence for signiﬁcant (N50%) coronary ﬂow lim-
iting lesion on angiography. As part of the study protocol, all patients
underwent CT coronary calciﬁcation assessment, dobutamine stress
echocardiography, comprehensive biochemistry and metabolomics
analysis aswell as detailed life style questionnaire. A total of 55 patients
(mean age± SD, 64.7± 7.6 years; 24males)were eligible for the study
analysis. No patients had reduced left ventricular (LV) systolic function,
more than mild valve disease, pulmonary hypertension, arrhythmia,
conduction abnormality, chronic renal failure or clinical evidence for
parathyroid disease. All patients gave a written informed consent for
participating in the study whichwas approved by the Ethics Committee
of Umea.
2.2. Clinical data
Baseline patient's characteristics, clinical details andmedications are
summarized in Table 1 (a and b). Conventional risk factors for CADwere
assessed as follows: body surface area (BSA) calculated in accordance
with previously described formula [4], systemic hypertension deﬁned
as documented history of high blood pressure with values N140/
85 mm Hg or taking antihypertensive medications; diabetes deﬁned
as raised fasting blood glucose levels (≥7 mmol/l) and/or history of tak-
ing hypoglycemic medications; family history in those with ﬁrst or sec-
ond degree relatives with CAD or sudden death; smoking if the patient
currently smoked or was a former smoker; dyslipidemia when total
serum cholesterol was N5.2 mmol/l or patients took statins. No patient
had previous history of coronary artery disease (acute coronary syn-
drome, percutaneous coronary intervention, coronary bypass surgery)
or cerebrovascular disease.Table 1
Baseline characteristics (a) and medications (b) of the whole population.
a)
Baseline characteristics CAC ≤ 100 CAC N 100 Chi square P value
Age (years) 63 ± 7 67 ± 8 – 0.96
Male gender (%) 15% 67% 15.9 0.00
BSA (m2) 1.75 ± 0.1 1.9 ± 0.1 – 0.7
Systemic hypertension 58% 82% 10.3 0.00
Diabetes 7% 18% 7.8 0.02
CAD family history 56% 64% 6.8 0.03
Smoking 37% 55% 8 0.01
Dyslipidemia 56% 73% 8 0.01
CACs 0 (0–17) 367 (133–801) – 0.00
Calcium disorders
(osteoporosis,
osteopenia, etc.)
19% 14% 6.7 0.03
b)
Medications CACs ≤ 100 CACs N 100 Chi square P value
β-Blockers 30% 32% 0.04 0.84
Ca-blockers 22% 29% 0.29 0.59
Nitrates 30% 39% 0.57 0.45
ACE-inhibitors 22% 29% 0.29 0.59
Diuretics 18% 25% 0.34 0.56
ARB 11% 7% 0.26 0.61
Calcium supplements 26% 7% 3.54 0.06
Aspirin 37% 50% 0.94 0.33
Values expressed as means ± SD (normal distributions), median and interquartiles (not-
normal, distributions), percentage (%) for categorical variables.2.3. CT coronary scan
Coronary Multidetector Computed Tomography (MDCT) was
performed using a 64-slice scanner (Light Speed VCT, XT; GE
Healthcare, Milwaukee, Wisconsin) with a gantry rotation time of
330 ms (collimation 64 × 0.6 mm, reconstruction increment
0.3 mm, tube voltage 100 kV). Image acquisition was performed
during inspiratory breath-hold. Patients whose heart rate was
N65 beat/min received metoprolol 100 mg orally, 1 h before the
CT examination. A non-enhanced scan was performed for CAC de-
tection, using prospective ECG triggering, usually at 70% of the RR
interval. The collimation was set to 30 × 0.6 mm and the reconstruct-
ed slice thickness was 3 mm (adapted ﬁeld of view depending on heart
size, matrix 512 × 512, pixel size usually 0.5 × 0.5 mm). CACS was cal-
culated using the Agatston method, which is determined by the calci-
ﬁed area and calcium score density [5]. Calcium was deﬁned as the
presence of N2 contiguous pixels with N130 Hounsﬁeld units and
these lesions were automatically identiﬁed and marked in colour by
the workstation. The ﬁnal value for CACS was calculated as the sum of
calcium scores in each coronary branch. An observer blinded to the an-
giogram results and clinical data, measured the CACS.
2.4. Echocardiographic examination
2.4.1. Image acquisition
Transthoracic echocardiographic examination was performed
using the conventional protocol and GE Vivid 7 or Philips EX 50
echocardiographs with appropriate transducers. Images were acquired
from standard views: apical 4 and 2 chamber, parasternal long and
short axis views according to the ASE/EAE recommendations [6]. Two-
dimensional grey scale images were obtained at a frame rate of 60–
80 frames/s at rest and stress. Three cardiac cycles were saved in digital
format onto a magneto-optical disc for off-line analysis (TomTec,
Philips).
2.4.2. Image analysis
Standard LVdiameters,wall thickness and LVmassweredetermined
according to the ASE recommendations. LV end-systolic and end-
diastolic volumes, stroke volume, and ejection fraction were measured
using the biplane modiﬁed Simpson's method. Left atrial volume was
also calculated using the area-length method (6). LV ﬁlling was studied
by pulsed wave Doppler, and peak early diastolic (E), late diastolic
(A) velocities, Ewave deceleration time (DT), and isovolumic relaxation
time (IVRT) were measured. The E/A and E/e′ ratios were calculated,
and used as indices of LV ﬁlling pressures [7].
Two-dimensional guided M-mode recording of septal, lateral, ante-
rior and inferior mitral annulus motion (long axis) was obtained from
the apical 4-chamber view, using the zoom function. Total amplitude
of systolic annular excursionwasmeasured from the pointmost distant
to the point most proximal to the LV apex. Overall mitral annular plane
excursion (MAPSE) was determined by averaging the excursion ampli-
tudes recorded at the four annular sites. Mitral annulus velocities were
also measured using pulsed Tissue Doppler (TDI) according to the cur-
rent ASE recommendations [8]. The average value of peak systolic (s′),
early diastolic (e′), and late diastolic (a′) mitral annulus velocities
were determined. Right ventricular free wall motion was similarly
studied by measuring tricuspid annulus plane systolic excursion
(TAPSE) and its systolic and early diastolic velocities. All measurements
were obtained by averaging values recorded from three consecutive
cycles, at a sweep speed of 100 mm/s.
2.4.3. Dobutamine stress echocardiography
Dobutamine stress echocardiography was performed according to
the EAE expert consensus statement [9]. Intravenous dobutamine was
administered at a starting dose of 5 μg/kg/min,with similar incremental
dose every 3 min to a maximum of 40 μg/kg/min. Additional dose of
Table 2
Haemodynamic and echocardiographic measurements between groups at rest and during
stress.
Variable Rest Stress
CACS ≤ 100 CACS N 100 CACS ≤ 100 CACS N 100
LVEF (%) § 67 (12%) 64 (13%) 72 (10%) 72 (12%)
(CI) 64–70 61–67 69–75 69–75
LA volume (ml/m2) 16.32 ± 4.6 21.01 ± 5.1 13.8 ± 4.3 18 ± 6.7
(CI) 14–18 18–23 12–16 14–22
SV (ml/m2) § 27 (26%) 25 (46%) 27 (28%) 28 (41%)
(CI) 25–30 21–31 25–31 23–33
E/A ratio § 1.00 (40%) 0.92 (41%) 0.88 (30%) 0.76 (36%)
(CI) 0.88–1.15 0.8–1.05 0.79–0.98 0.67–0.86
Mitral e′ (cm/s) § 11.1 (38%) 8.6 (31%) 11.4 (18%) 9.1 (32%)
111E. Palmerini et al. / IJC Heart & Vasculature 9 (2015) 109–114atropine (300 μg) was given if adequate heart rate response was not
achieved. Heart rate, systemic blood pressure and ECG were monitored
at baseline, during all stages of the stress protocol and during recovery.
Standard stress end-points were symptoms i.e. angina, ischaemic ECG
changes (N1 mm ST shift), arrhythmia, hyper or hypotension (a rise in
systolic blood pressure N220 mm Hg or drop by ≥20 mm Hg). LV wall
motion function was assessed at the end of stress and compared with
resting scores, by an expert in stress echocardiography blinded to the
results of angiographic studies. Wall motion score index (WMSI) was
obtained as the average of individual LV segments, scoring 1 for normal,
2 for hypokinesia, 3 for akinesia, and 4 for dyskinesia. Segmental LV
function using various techniques described above was repeated at
peak stress.(CI) 9.8–12.7 7.7–9.7 10.6–12.2 8.0–10.3
Mitral s′ (cm/s) 10.4 ± 1.9 9.6 ± 2.2 14.1 ± 2.6 14.7 ± 3.4
(CI) 10–11 9–11 13–15 13–16
Mitral a′ (cm/s) 13.1 ± 2 12.1 ± 1.8 14.7 ± 2.5 15.6 ± 3.3
(CI) 12–14 11–13 14–16 14–17
E/e′ ratio § 7.0 (60%) 8.8 (40%) 7.2 (30%) 7.9 (42%)
(CI) 5.8–8.6 7.5–10.2 6.4–8.0 6.7–9.4
MAPSE (mm) 13.8 ± 1.4 13.8 ± 2 14.6 ± 1.8 14.4 ± 32.4.4. Coronary angiography
All patients had undergone a standard coronary angiogramusing the
Judkins technique. Coronary vessels and stenoseswere assessed accord-
ing to the recommendation of the American Heart Association [10].
Signiﬁcant stenosis was deﬁned as ≥50% luminal narrowing.(CI) 13–14 13–15 14–16 13–16
Values shown as means ± SD for normal distributed variables; § = log-transformed
variables shown as geometric means and geometric SD (%) and conﬁdence interval (CI).
LVEF = left ventricle ejection fraction; LA volume = indexed left atrial volume;
SV = indexed stroke volume; mitral E = transmitral ﬂow early-diastolic wave;
mitral A = transmitral ﬂow late-diastolic wave;mitral e′ = Tissue Doppler early diastol-
ic velocity wave; mitral s′ = Tissue Doppler systolic velocity wave; mitral a′ = Tissue
Doppler late diastolic velocity wave; MAPSE = mitral annular-plane systolic excursion.3. Statistical analysis
Statistical analysis was performed using SPSS for Windows (SPSS,
version 16.0, IL, USA) and Stata 11.0 (StataCorp LP, TX, USA). Patients
were classiﬁed into 2 groups: Group 1, 27 subjects with mild coronary
calciﬁcation (CACS ≤ 100) and Group 2, 28 subjects with more than
mild (CACS N 100). Baseline differences between groups were assessed
by Chi square test. For the echocardiographic assessment we used two
multivariate linear regression models and all dependent variables
were gender-standardized. In each model we included age, BSA, CV
risk factors and calcium disorders as independent variables. βz values
were obtained to reﬂectmean differences between groups per standard
deviation (SD) on Z-scale and β value for signiﬁcant differences was
reported. The assumption of linearitywas checked graphically by study-
ing the residuals from the null models plotted against the covariate
variables. Dependent variables not-normally distributedwere log trans-
formed using the natural logarithmic scale before the analysis and then
reported as geometric mean and SD for easier interpretation of data. Po-
tential association between variables was assessed by Pearson's correla-
tion coefﬁcient. WMSI abnormalities were analysed using Chi square
test. The intra-class and inter-class correlation coefﬁcients (ICCs) were
used to assess the consistency and reliability of results and the coefﬁ-
cient of variation (CV) was calculated for MAPSE and mitral s' wave.
For conﬁrming our results anothermultivariate statistical analysiswas
performed using SIMCA-P (version 12,MKS-Umetrics AB, Umeå). All data
were mean-centred and scaled to unit variance (variance = 1) prior to
any multivariate modelling. Orthogonal partial least squares (OPLS)
were used for calculating multivariate regression models, while OPLS-
discriminant analysis (OPLS-DA) was used for calculating multivariate
classiﬁcation models. We analysed the effects of CAC between groups at
rest and stress and within groups. This was done by classiﬁcationmodel-
ling to reveal CAC speciﬁc alterations on a group level and by regression
modelling to reveal a continuous variation in CAC levels over the high
CAC samples only. Model validation was carried out by means of 7-fold
full cross validation and by calculation of probability values (95%) for
the cross-validated models using ANOVA.4. Results
Table 1 summarizes baseline characteristics (a) and medications
(b) of the population. A different distribution in gender, hypertension,
diabetes, smoking, dyslipidemia, CAD family history and calcium disor-
ders was observed between the two groups. Table 2 summarizes echo-
cardiographic ﬁndings.4.1. Rest
As shown in Tables 2 and 3, Group 2 patients had larger LA volume at
baseline (βz 1.06 SD, pb 0.05, R2 0.37, approximatelyβ6ml/m2), reduced
MAPSE (βz−1.11 SD, p b 0.05, R2 0.6, approximately β−2 mm) as well
as its systolic (s′) and late diastolic (a′) velocities (βz −1.08 SD,
p b 0.05, R2 0.44, approx β −2 cm/s and βz −1.05 SD, p b 0.05, R2
0.35, approx β −2 cm/s, respectively). MAPSE correlated with its s′
only in Group 1 (r = 0.54, p b 0.05) at baseline but not in Group 2
(Fig. 1).
4.2. Stress
The stress echocardiogram was completed in all patients (inclusion
criterion). Group 1 patients, except one, did not develop signiﬁcant
WM abnormalities, angina symptoms or ischaemic ECG changes but
eight patients in Group 2 developed ischaemic ECG changes, angina
like symptoms andWMabnormalities (Chi square : 6.2, p b 0.05). In ad-
dition, two patients in Group 2 developed paroxysmal supraventricular
arrhythmia during stress.
4.3. Rest vs stress
The delta change of echocardiographic variables corrected for risk
factors (Table 3) did not show any signiﬁcant difference between
groups including LVEF, Doppler and M-mode measurements.
4.4. Multivariate analysis
A signiﬁcant classiﬁcation model was obtained for the difference be-
tween low and high CACS (Group 1 vs Group 2; p = 0.014) based on all
measured variables. Following variable selection including only those sig-
niﬁcantly contributing to the class difference the multivariate difference
between Groups was highly signiﬁcant (p = 3.5 ∗ 10−6). Furthermore,
applying a multivariate regression approach based on rest and stress pa-
rameters showed signiﬁcant correlation with CACS (p = 0.003; Fig. 2a).
Table 3
Gender-standardized model analysing mean differences in echocardiographic measurements between and within groups at rest and stress.
Variable Rest Stress Rest vs stress
βz CI 95%
lower
CI 95%
upper
p value R2 βz CI 95%
lower
CI 95%
upper
p value R2 βz CI 95%
lower
CI 95%
upper
p value R2
LVEF (%) 0.55 0.25 1.21 0.13 0.25 1.25 0.6 2.71 0.56 0.14 2 0.96 3.73 0.04⁎ 0.49
LA vol (ml/m2) 1.06 0.27 1.84 0.01⁎ 0.37 0.57 −0.4 1.54 0.24 0.35 −0.16 −0.66 0.34 0.52 0.85
SV (ml/m2) 0.81 0.4 1.62 0.54 0.43 1.15 0.51 2.6 0.72 0.28 1.5 1 2.21 0.06 0.83
Mitral E/A ratio 0.98 0.45 2.14 0.96 0.21 0.64 0.27 1.5 0.3 0.26 0.66 0.32 1.35 0.24 0.50
mitral e′ 0.81 0.37 1.77 0.59 0.37 0.9 0.36 2.1 0.73 0.40 1.05 0.61 1.8 0.86 0.79
mitral s′ −1.08 −1.95 −0.21 0.01⁎ 0.44 0.31 −0.44 1.1 0.40 0.47 0.8 −0.07 1.68 0.07 0.53
mitral a′ −1.05 −2.01 −0.1 0.03⁎ 0.35 −0.13 −0.92 0.66 0.74 0.47 0.54 −0.3 1.34 0.18 0.57
E/e′ ratio 1.41 0.65 3.03 0.36 0.23 1 0.36 2.84 0.981 0.17 0.7 0.31 1.54 0.35 0.55
MAPSE (mm) −1.11 −1.9 −0.32 0.00⁎ 0.56 −0.37 −1.81 1.1 0.6 0.48 −0.03 −1.02 0.97 0.95 0.87
βz = coefﬁcient (per 1 SD increase in a variable), CI = conﬁdence interval, values are adjusted for covariates.
⁎ p b 0.05 was considered statistically signiﬁcant.
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mean MAPSE and global longitudinal systolic strain and early diastolic
strain rate. Also resting and stress TAPSE lengthening velocity correlated
with CACS (w ∗ 1, Fig. 2b).
4.5. Reproducibility
Between observer agreement was satisfactory with a median
InterCC value of 0.87 and a range of 0.65–0.99 as well as repeatability
of all measurements for the same observer with a median IntraCC of
0.88 and a range of 0.66–0.99. Coefﬁcient of variation was calculated
for the most clinically relevant parameters and didn't exceed 5% for
rest and 7% for stress (both below the critical 10% threshold).
5. Discussion
5.1. Findings
The present study describes a group of symptomatic patients
with exertional angina who all proved to have no coronary lumen
stenosis, normal LV structure and function measurements at rest,
with normal EF and ﬁlling velocities. However, detailed assessment
of cardiac function revealed a number of disturbances. MAPSE was
abnormal in both systole and diastole, showing reduced amplitudeFig. 1.MAPSE and S′ trend in both CACs groups : a correlation exists at baseline between
MAPSE and S′ only in group 1 (higher CACs).of motion and velocities. The mitral annular displacement during
systole lost its normal relationship with systolic velocities in patients
with CACS N100 [11]. Also, in the same group of patients the left atri-
al volumewas relatively increased and its systolic velocities reduced.
At peak stress, the same group of patients, with CACS N100, devel-
oped increased wall motion score index and classical ischaemic
ECG changes when it became symptomatic. None of these distur-
bances appeared in patients with CACS b100. Finally, our analysis
showed a direct relationship between the severity of CAC and stress
induced myocardial abnormalities.
5.2. Data interpretation
Our results show that syndrome X patients with more than mild
CACS have signiﬁcant resting and stress induced ischaemic distur-
bances. Resting segmental LV long axis disturbances are consistent
with what we previously reported [12], which seem to correlate with
the extent of myocardial perfusion abnormalities, syndrome X patients
develop with stress. The stress induced disturbances we observed in
this study are of the same nature, reduced amplitude of motion and ve-
locities as well as raised WMSI, again similar to what we and others
have previously shown in patients with coronary artery stenosis [13,
14], thus conﬁrming that they are likely ischaemic in origin. The absence
of signiﬁcant stenosis in our patients however suggests a different
pathophysiological explanation, related to the presence of signiﬁcant
coronary wall calciﬁcation, as shown by our multivariate analysis
modelling. Signiﬁcant calciﬁcation causes coronary wall hardening
and compromisedﬂow reserve, which overtimepreconditions themyo-
cardium and recruits collaterals [15]. This however, does not guarantee
optimummyocardial blood supply at the time of stress, hence ischaemic
disturbances and symptoms. A further conﬁrmation of this interpreta-
tion is proved by the relative enlargement of the left atrium seen in pa-
tients with CACs N100, in keeping with previous studies [16], although
somewhat complex to interpret. The reduced MAPSE and long axis am-
plitude of motion compromises left atrial emptying and consequently
raised cavity pressure, which itself could contribute to some patients'
breathlessness. The increase in WMSI with stress in patients with
CACs N100 is of particular interest. It has been shown, in numerous
studies, as a conventional sign of ischaemic dysfunction [17,18], having
never featured other cardiac conditions e.g. hypertension. Therefore we
are not in doubt that the pattern documented in our patients reﬂects
underlying ischaemic pathophysiology which is uncovered at fast
heart rate as a result of suboptimal coronary ﬂow reserve. This interpre-
tation is supported by previously publishedwork showing stress related
wall motion abnormalities and myocardial perfusion disturbances in
patients with coronary calciﬁcation [19].
Away from highly specialised centres, our patients with CACS N100
represent those carrying an intermediate risk for CV events, who are
considered safe and are likely to be discharged from cardiology clinics.
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113E. Palmerini et al. / IJC Heart & Vasculature 9 (2015) 109–114Our results clearly show that their exertional symptoms are ischaemic
in origin. Since the only pathophysiology identiﬁed is coronarywall cal-
ciﬁcation, it is unlikely for them to respond to conventional vasodilators,
and hence the clinical dilemma [20]. The scenario is further complicated
by the natural history of coronary calciﬁcation as has previously been
shown in large population studies [21,22] which all showed that ‘calci-
um begets calcium’. Therefore, a patientwith a CACS of 50 is likely to in-
crease it by 50 in few years compared to another with a CACS of 1000
which will become 2000 within the same time period. In our cohort of
patients, 12 of Group 2 patients had CACS of N400 considered as severe
by conventional measures.5.3. Limitations
We did not measure coronary ﬂow reserve in our patients since it
was not part of the study protocol, being non-invasive in nature. Inva-
sive assessment of coronary ﬂow properties or myocardial perfusion
tests in such patients would have better supported our data interpreta-
tion. The exact explanation of Group 1 patient's symptoms remains to
be determined. With potential variability of CACS measurements
depending on the CT system used, it is recommended that patient
follow-up calcium scoring should be obtained using the same scanner
and protocol.
114 E. Palmerini et al. / IJC Heart & Vasculature 9 (2015) 109–1145.4. Clinical implications
Symptomatic patients who do not show evidence for signiﬁcant
stenosis on conventional angiography may beneﬁt from CT coronary
calcium score assessment which might reveal an alternative explana-
tion for their symptoms. The exact interrelations between coronary
calciﬁcation, exertional symptoms and ischaemic dysfunction, in these
patients, remain to be better understood. At present, such patients
might beneﬁt from heart rate control, e.g. beta blockers or ivabradine
rather than conventionally used vasodilators, in keepingwith the recent
evidence [22].
5.5. Conclusions
Coronary calciﬁcation, more thanmild, contributes to restingmyocar-
dial dysfunction in patients suffering from exertional angina in the
absence ofﬂow limiting lesions. A clearer evidence for such interpretation
is seen with increase in heart rate, at the time of symptom development,
suggesting compromised coronary ﬂow reserve. Further explanation
of symptoms of mild CAC patients remains to be determined.
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